Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Anheart, Applied DNA Sciences, Astrazeneca, Bellerophon, Can-Fite, Cansino Biologics, Cytodyn, Genentech, Hansoh, Merck, Novartis, Synairgen, Takis.